Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
3
×
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3
×
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
car-t immunotherapy
crispr
deals
fda
What
bio
companies
3
×
roundup
drug
nash
news
approval
approved
biogen’s
biopharmaceutical
black
continue
convo
debut
diamond
diamond’s
digital
disease
earlier
epidemic
failures
fatty
fda
frenzied
growing
indication
known
leading
led
life
littered
liver
mammoth
march
merck
moves
new
ohana’s
pop
price
Language
unset
Current search:
merck
×
companies
×
" seattle blog main "
×
" wisconsin top stories "
×
startups
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More